"Sobi in
Duane was most recently President of
He has a strong background in the US healthcare sector and lengthy experience working cross-functionally to find new ways to deliver value to patients living with severe diseases. Duane has a MSc and MBA from the
Duane will join Sobi in
About Sobi[TM]
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. Sobi is providing sustainable access to innovative therapies in the areas of haematology, immunology and specialty indications. Today, Sobi employs approximately 1,500 people across Europe, North America, the Middle East, Russia and North Africa. In 2019, Sobi's revenue amounted to SEK 14.2 billion. Sobi's share (STO:SOBI) is listed on Nasdaq Stockholm. You can find more information about Sobi at www.sobi.com.
Contact
Paula Treutiger, Head of Communication & Investor Relations
+46 733 666 599
paula.treutiger@sobi.com
Postal address SE-112 76
Phone: 46 8 697 20 00 www.sobi.com
https://news.cision.com/swedish-orphan-biovitrum-ab/r/sobi-appoints-new-head-of-north-america-ahead-of-launch-phase,c3260295
https://mb.cision.com/Main/14266/3260295/1352904.pdf
(c) 2020 Cision. All rights reserved., source